glp 1 drug differences Understanding Weight Loss Medications: GLP-1 vs. Phentermine Mounjaro and Ozempic are NOT

Discussion The results of this population based cohort study, designed to emulate a randomised controlled trial, suggest that the combined use of GLP-1 receptor agonists and SGLT-2 inhibitors is associated with a reduced risk of major adverse cardiovascular events and serious renal events, compared with using either drug class alone

Investigation 122 (1), 388402

A., Casey, R

doi: 10.1016/j.peptides.2017.11.023

[DOI] [PubMed] [Google Scholar] 58.Kwon G., et al

Researchers Analyzed Real-World Patient Outcomes The team used Optum Market Clarity, a US electronic health record and insurance claims database, to analyze patients who started liraglutide, semaglutide, or tirzepatide between January 2021 and June 2024